Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, USA.
Head Neck. 2012 Jun;34(6):900-6. doi: 10.1002/hed.21677. Epub 2011 Jan 31.
No universal consensus of optimal radiation target coverage for oral tongue cancer exists, and there is wide variability in practice. Some centers use intensity-modulated radiotherapy (IMRT) to selectively target only certain regions at risk while sparing others; however, patterns of failure after such selective targeting are rarely reported.
We critically examined the location of failure in 4 patients with stage III to IV oral tongue cancer who presented to our department with locoregional recurrence after receiving IMRT with selective radiation targeting at outside institutions. All 4 patients' cancer recurred marginally in regions that were not initially targeted, whereas the regions would have been targeted if comprehensive IMRT targeting had been used. The median time to recurrence was short (3.9 months; range, 1.2-10.1 months).
This case series highlights the occurrence of marginal failures after selective targeting with IMRT for oral tongue cancer and cautions against this practice unless further supporting evidence becomes available.
目前对于口腔舌癌的最佳放射靶区覆盖范围尚未达成普遍共识,而且实际操作差异很大。一些中心使用调强放疗(IMRT)有选择地仅针对某些风险区域进行靶向治疗,同时保护其他区域;然而,针对这种选择性靶向治疗后失败的模式很少有报道。
我们仔细检查了在 4 名接受选择性放射靶向治疗的 III 期至 IV 期口腔舌癌患者中的失败位置,这些患者在外部机构接受 IMRT 治疗后出现局部区域复发。所有 4 名患者的癌症均在最初未靶向的区域边缘复发,而如果使用全面的 IMRT 靶向治疗,则这些区域将会被靶向。复发的中位时间较短(3.9 个月;范围,1.2-10.1 个月)。
本病例系列强调了口腔舌癌选择性靶向治疗后边缘失败的发生,并警告不要采用这种治疗方法,除非有更多的支持证据。